Burchardt, E.; Burchardt, W.; Cegła, P.; Kubiak, A.; Roszak, A.; Cholewiński, W.
Pretreatment [18F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1. Diagnostics 2021, 11, 714.
https://doi.org/10.3390/diagnostics11040714
AMA Style
Burchardt E, Burchardt W, Cegła P, Kubiak A, Roszak A, Cholewiński W.
Pretreatment [18F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1. Diagnostics. 2021; 11(4):714.
https://doi.org/10.3390/diagnostics11040714
Chicago/Turabian Style
Burchardt, Ewa, Wojciech Burchardt, Paulina Cegła, Anna Kubiak, Andrzej Roszak, and Witold Cholewiński.
2021. "Pretreatment [18F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1" Diagnostics 11, no. 4: 714.
https://doi.org/10.3390/diagnostics11040714
APA Style
Burchardt, E., Burchardt, W., Cegła, P., Kubiak, A., Roszak, A., & Cholewiński, W.
(2021). Pretreatment [18F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1. Diagnostics, 11(4), 714.
https://doi.org/10.3390/diagnostics11040714